NDC 57970-100 – Dalvance

Dalbavancin Hydrochloride 500 mg/25mL · Injection, Powder, For Solution · Intravenous

Human Prescription Drug

Product NDC57970-100

Product details

Brand name
Dalvance
Generic name
Dalbavancin
Labeler
Allergan, Inc.
Dosage form
Injection, Powder, For Solution
Route
Intravenous
Marketing category
NDA · NDA021883
Marketed since
May 23, 2014
Listing expires
December 31, 2026
Pharmacologic class
Lipoglycopeptide Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Dalvance →

Package NDC codes (1)

Package NDCDescriptionSince
57970-100-011 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIALMay 23, 2014